Marshall Wace North America L.P. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$9,484,000
-42.8%
214,034
-26.7%
0.04%
-42.9%
Q2 2021$16,588,000
-52.0%
291,989
-36.8%
0.07%
-51.4%
Q1 2021$34,558,000
-44.6%
461,701
-36.0%
0.14%
-49.3%
Q4 2020$62,383,000
+141.9%
721,108
+70.9%
0.28%
+72.1%
Q3 2020$25,789,000
+9381.2%
421,939
+4349.9%
0.16%
+8150.0%
Q1 2020$272,000
-98.8%
9,482
-94.3%
0.00%
-98.5%
Q3 2019$23,437,000
+1.4%
167,060
+32.4%
0.13%
-7.0%
Q2 2019$23,109,000
-86.6%
126,217
-88.3%
0.14%
-76.5%
Q1 2019$171,904,000
+268.7%
1,080,816
+122.1%
0.61%
+35.0%
Q4 2018$46,621,000
-66.3%
486,704
-50.2%
0.45%
-5.1%
Q3 2018$138,184,000
+67.3%
978,296
+85.4%
0.48%
+1.9%
Q2 2018$82,588,000
-18.9%
527,616
-16.5%
0.47%
-8.6%
Q1 2018$101,812,000
-3.0%
632,100
-0.8%
0.51%
-12.1%
Q4 2017$104,923,000
+2870.6%
637,017
+1018.3%
0.58%
+2536.4%
Q3 2017$3,532,000
-87.1%
56,961
-83.4%
0.02%
-89.0%
Q2 2017$27,379,000
-22.9%
342,238
-31.5%
0.20%
-28.6%
Q1 2017$35,493,000499,9050.28%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,966,688$120,204,00010.81%
Integral Health Asset Management, LLC 230,000$14,058,0004.30%
Asymmetry Capital Management, L.P. 102,462$6,262,0004.02%
ACUTA CAPITAL PARTNERS, LLC 225,000$13,752,0003.74%
DAFNA Capital Management LLC 158,306$9,676,0003.14%
Bain Capital Life Sciences Investors, LLC 499,100$30,505,0002.84%
Boxer Capital, LLC 1,094,000$66,865,0002.31%
Palo Alto Investors LP 590,200$36,073,0001.98%
Logos Global Management LP 250,000$15,280,0001.96%
Bellevue Group AG 1,579,504$96,539,0001.33%
View complete list of SAGE THERAPEUTICS INC shareholders